JACOBS LEVY EQUITY MANAGEMENT, INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$12,254,000
-16.2%
704,024
-19.0%
0.13%
-19.6%
Q2 2020$14,623,000
+146.9%
869,400
+74.5%
0.16%
+107.9%
Q1 2020$5,923,000
+564.8%
498,130
+910.2%
0.08%
+375.0%
Q4 2017$891,000
+133.2%
49,310
+148.9%
0.02%
+128.6%
Q3 2017$382,000
+526.2%
19,810
+22.3%
0.01%
+600.0%
Q3 2015$61,00016,2000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders